Investors should take notice of NASDAQ:JAZZ—it offers a great deal for the fundamentals it presents.

JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) has caught the attention of our stock screener as a great value stock. NASDAQ:JAZZ excels in profitability, solvency, and liquidity, all while being very reasonably priced. Let's delve into the details.

Valuation Examination for NASDAQ:JAZZ

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:JAZZ has achieved a 9 out of 10:

• A Price/Earnings ratio of 6.30 indicates a rather cheap valuation of JAZZ.
• Based on the Price/Earnings ratio, JAZZ is valued cheaper than 96.77% of the companies in the same industry.
• The average S&P500 Price/Earnings ratio is at 28.42. JAZZ is valued rather cheaply when compared to this.
• The Price/Forward Earnings ratio is 5.55, which indicates a rather cheap valuation of JAZZ.
• Based on the Price/Forward Earnings ratio, JAZZ is valued cheaply inside the industry as 95.70% of the companies are valued more expensively.
• The average S&P500 Price/Forward Earnings ratio is at 24.39. JAZZ is valued rather cheaply when compared to this.
• 90.86% of the companies in the same industry are more expensive than JAZZ, based on the Enterprise Value to EBITDA ratio.
• Based on the Price/Free Cash Flow ratio, JAZZ is valued cheaply inside the industry as 95.70% of the companies are valued more expensively.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• The decent profitability rating of JAZZ may justify a higher PE ratio.

Profitability Examination for NASDAQ:JAZZ

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:JAZZ, the assigned 7 is a significant indicator of profitability:

• JAZZ's Return On Assets of 3.78% is amongst the best of the industry. JAZZ outperforms 86.56% of its industry peers.
• JAZZ has a better Return On Equity (11.10%) than 89.78% of its industry peers.
• JAZZ's Return On Invested Capital of 4.95% is amongst the best of the industry. JAZZ outperforms 81.72% of its industry peers.
• The last Return On Invested Capital (4.95%) for JAZZ is above the 3 year average (3.02%), which is a sign of increasing profitability.
• With an excellent Profit Margin value of 11.60%, JAZZ belongs to the best of the industry, outperforming 87.63% of the companies in the same industry.
• JAZZ has a better Operating Margin (17.62%) than 84.95% of its industry peers.
• JAZZ has a Gross Margin of 89.37%. This is amongst the best in the industry. JAZZ outperforms 92.47% of its industry peers.

What does the Health looks like for NASDAQ:JAZZ

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:JAZZ was assigned a score of 5 for health:

• Looking at the Altman-Z score, with a value of 1.51, JAZZ is in the better half of the industry, outperforming 62.37% of the companies in the same industry.
• The Debt to FCF ratio of JAZZ (5.55) is better than 86.56% of its industry peers.
• JAZZ has a Current Ratio of 4.26. This indicates that JAZZ is financially healthy and has no problem in meeting its short term obligations.
• JAZZ has a better Current ratio (4.26) than 61.29% of its industry peers.
• A Quick Ratio of 3.74 indicates that JAZZ has no problem at all paying its short term obligations.

Growth Assessment of NASDAQ:JAZZ

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:JAZZ was assigned a score of 5 for growth:

• The Earnings Per Share has grown by an impressive 48.22% over the past year.
• JAZZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.19% yearly.
• Based on estimates for the next years, JAZZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.14% on average per year.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

Our Decent Value screener lists more Decent Value stocks and is updated daily.

Check the latest full fundamental report of JAZZ for a complete fundamental analysis.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.